Product image of Ibandronsav Synthon (Ibandronic Acid) supplied by GNH India

Ibandronsav Synthon

Active Ingredient:
Ibandronic Acid
Origin:
EU

Ibandronsav Synthon (Ibandronic Acid)

Ibandronic acid, the active ingredient in Ibandronsav Synthon, is a bisphosphonate presented as an oral dosage form for oral use. It is indicated for the treatment of osteoporosis in postmenopausal women and for Paget's disease of bone.

GNH India supplies Ibandronsav Synthon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution originating from the European market. The company adheres to stringent and reliable quality standards and provides regulatory documentation for each batch throughout the supply chain.

Manufacturer / TM Owner

Synthon Bv

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ibandronsav Synthon (ibandronic acid) is used in the management of bone‑remodeling disorders.

  • Osteoporosis in postmenopausal women: reduces risk of vertebral and hip fractures by increasing bone mineral density.
  • Osteoporosis in men: improves bone density and lowers fracture incidence.
  • Paget's disease of bone: normalizes abnormal bone turnover and alleviates bone pain.

How It Works

  • Ibandronic acid binds selectively to hydroxyapatite crystals at sites of active bone remodeling. When osteoclasts attach to the drug‑coated bone surface, the compound is internalized, inhibiting the mevalonate pathway and inducing osteoclast apoptosis. This reduces bone resorption, allowing osteoblasts to restore bone mass and improve skeletal strength. The high affinity for bone mineral ensures prolonged retention, providing sustained anti‑resorptive activity after a single weekly dose.

Side Effects

Ibandronsav Synthon may be associated with a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects

  • Gastrointestinal irritation: dyspepsia, abdominal pain, or nausea.
  • Diarrhea: loose stools occurring shortly after dosing.
  • Musculoskeletal pain: bone, joint or muscle discomfort.
  • Transient flu‑like symptoms: fever, chills, or myalgia after the first dose.
  • Headache: mild to moderate intensity.

Serious or Rare Side Effects

  • Osteonecrosis of the jaw: exposed necrotic bone in the maxillofacial region.
  • Atypical femur fracture: low‑energy subtrochanteric or diaphyseal fracture.
  • Severe hypersensitivity: rash, angioedema, or anaphylactic reaction.
  • Acute phase reaction: severe flu‑like symptoms with high fever and malaise.
  • Renal impairment: acute kidney injury, especially with high doses.

Precautions & Warnings

Before initiating Ibandronsav Synthon, several precautionary measures should be considered to minimize risk.

  • Renal function assessment: evaluate creatinine clearance and avoid use in severe renal impairment.
  • Calcium and vitamin D status: ensure adequate supplementation to reduce hypocalcemia risk.
  • Concomitant NSAID or corticosteroid use: monitor for gastrointestinal ulceration or enhanced bone loss.
  • Dental health review: perform oral examination and treat existing infections to lower jaw osteonecrosis risk.
  • Avoid excessive alcohol: limit intake as it may increase fracture risk.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Ibandronsav Synthon can interact with several medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid)

  • Concurrent bisphosphonate therapy: additive anti‑resorptive effect may increase adverse events.
  • High‑dose calcium or multivitamin supplements taken within 2 hours of dosing: markedly reduces ibandronate absorption.
  • Antacids containing aluminum, magnesium, or calcium taken simultaneously: chelation interferes with drug uptake.

Moderate Interactions (Monitor Closely)

  • NSAIDs: combined use may heighten gastrointestinal irritation.
  • Corticosteroids: may counteract bone‑protective benefits and increase fracture risk.

Frequently Asked Questions

Ibandronsav Synthon contains ibandronic acid, a bisphosphonate indicated for the treatment of osteoporosis in postmenopausal women and men, as well as for Paget's disease of bone. It works by reducing bone resorption, thereby strengthening the skeleton and lowering fracture risk.

Ibandronic acid binds to hydroxyapatite at active bone remodeling sites. When osteoclasts attach to the drug‑coated surface, the compound is taken up and blocks the mevalonate pathway, leading to osteoclast apoptosis. This inhibition of bone resorption allows bone formation to predominate.

The dosing regimen for Ibandronsav Synthon is determined by the prescribing clinician based on the specific indication, patient characteristics, and renal function. The product is supplied as a prescription‑only medication, and the prescriber will provide individualized dosing instructions.

Ibandronic acid is classified as contraindicated in pregnancy and is not recommended for breastfeeding mothers because safety data are limited. Women of childbearing potential should use effective contraception during treatment and discuss any concerns with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ibandronsav Synthon (ibandronate) is typically administered once weekly, whereas agents such as alendronate are taken daily or weekly and risedronate may be taken weekly or monthly. Ibandronate has a high affinity for bone mineral, offering sustained anti‑resorptive activity with a convenient dosing schedule, but the safety profile and contraindications are similar across the class.

Store the product at room temperature, below 25 °C, in the original packaging to protect it from moisture and direct sunlight. Keep the container tightly closed and out of reach of children. Do not refrigerate or freeze the tablets.

Ibandronsav Synthon is taken orally, usually on an empty stomach with a full glass of water. Patients should remain upright for at least 30 minutes after dosing and avoid eating, drinking, or taking other medications during that period to ensure optimal absorption.

Serious adverse events include osteonecrosis of the jaw, atypical femur fractures, severe hypersensitivity reactions, acute phase reactions with high fever, and renal impairment. Patients should be monitored for signs of these conditions and advised to seek immediate medical attention if they occur.

Ibandronsav Synthon should be avoided in patients with severe renal impairment (creatinine clearance <30 mL/min), known hypersensitivity to ibandronate or other bisphosphonates, active upper gastrointestinal disorders, or those who are pregnant or breastfeeding. A thorough medical assessment is required before initiating therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ibandronic Acid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT